Vista Outdoor Confirms CSG Increases Purchase Price for The Kinetic Group Business by $50 Million to $1.96 Billion
Cash Consideration Delivered at Closing in CSG Transaction Increased 24% or $3.10 per share from $12.90 to $16.00 per share of Vista Outdoor Common Stock ANOKA,... Read more.
Austria Prepaid Card and Digital Wallet Business Report 2024-2028: Market Size and Forecast, Consumer Attitude & Behaviour, Retail Spend Across 11 Categories and 12 Segments – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Austria Prepaid Card and Digital Wallet Business and Investment Opportunities Databook – Market Size and Forecast,... Read more.
Asia-Pacific Assessment of Stealth Fighter and Bomber Industry Outlook and On-going Programs Research 2025-2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Assessment of Stealth Fighter and Bomber Market: Focus on Application and Country – Analysis and... Read more.
Dopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia
Safe and Tolerable: MyopiaX-1 proof-of-concept clinical trial (NCT04967287) supports MyopiaX’s excellent safety and tolerability profile with no untoward safety... Read more.
T-Mobile to Acquire UScellular Wireless Operations and Deliver Exceptional Value, a Superior 5G Experience and Unparalleled Benefits to Millions of Customers
Un-carrier Will Give UScellular and T-Mobile Customers More Value and Better Experiences, and Spur Growth and Competition that Offers More Choice for Wireless Consumers... Read more.
FourKites Signs on as Collaborator to Consortium of Supply Chain Leaders Working to Streamline Scheduling Technology Across the Logistics Industry
FourKites is the first real-time visibility platform participating in the SSC CHICAGO–(BUSINESS WIRE)–Leading real-time supply chain visibility provider... Read more.
DeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough
Inspired Chemistry™ platform eliminates manual chemical synthesis as a key bottleneck in drug discovery with automated high-throughput, multi-step synthesis to... Read more.
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class... Read more.
Aramark to Participate in Upcoming Investor Conferences
PHILADELPHIA–(BUSINESS WIRE)–Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that members of its executive management... Read more.
Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Oral presentation to highlight safety and preliminary efficacy of EIK1001 in combination with pembrolizumab Separate poster presentations will highlight EIK1001... Read more.